The Ivoclar group has achieved a strong turnover of over 840 million Swiss francs in 2021, according to the company’s press release.
The Liechtenstein-based dental and medical technology company said the strong growth represents highest sales turnover in its history. The company credits its successful introduction of new products, new geographical market expansion and a rebranding exercise as key factors.
Despite the industry-wide slump in 2020, the Ivoclar Group not only managed to bounce back, but also surpass its 2019 turnover record. The > 840 million Swiss francs performance represents a 31.2 per cent and 7.8 per cent jump over 2020 over 2019 figures respectively.
According to the Group, they were “minimally affected” by the 2020 dental industry slowdown, which caused many dental offices and laboratories to close temporarily. The European company said it managed to minimise the effects due to three main factors: A foresighted procurement policy; careful logistics planning and highly motivated employees.
The Group’s dentist business grew by +39.2 per cent compared with 2020 figures. Direct restoratives in particular recorded a big rise on the back of high demand for filling materials. Other product groups associated with the restorative treatment process also experienced a sales bump. Among the well-performing products were Adhese Universal bonding agent and OptraGate.
As a supplier of dental lab materials and millable ceramic blanks – the zirconium oxide discs, such as IPS e.max, and the 2021-launched ZirCAD Prime Esthetic – the Group also performed well in the category for prosthetic products. In addition, the company introduced a new furnace, the Programat CS6, in 2021.
Overall, their lab-side business grew by 23.1 per cent, largely due to the sales performance of their digital solutions.
Across the board and geographical markets, sales of the Ivoclar Group experienced a substantial increase in sales volume: 17.2 per cent in Asia Pacific, 36 per cent in North America, 61.3 per cent in Latin America and 31 per cent in EMEA (Europe, Near East and Africa). Specifically, the markets that recorded the biggest increases were: India (89.6 per cent), Brazil (72.2 per cent), Mexico (46.8 per cent) and China (16 per cent).
Due to COVID-19 restrictions, the Ivoclar Group has not been able to participate in trade shows or in-person training courses around the world, they remain upbeat about their ability to adapt in these challenging times.
“Nonetheless, we were able to provide optimum service to our customers in all areas during these challenging times by developing creative solutions,” said Diego Gabathuler, CEO of the Ivoclar Group.
Through its new Ivoclar Academy online knowledge platform, the company provided remote learning opportunities as well as an international event series known as “The Live Experience Tour”.
The information and viewpoints presented in the above news piece or article do not necessarily reflect the official stance or policy of Dental Resource Asia or the DRA Journal. While we strive to ensure the accuracy of our content, Dental Resource Asia (DRA) or DRA Journal cannot guarantee the constant correctness, comprehensiveness, or timeliness of all the information contained within this website or journal.
Please be aware that all product details, product specifications, and data on this website or journal may be modified without prior notice in order to enhance reliability, functionality, design, or for other reasons.
The content contributed by our bloggers or authors represents their personal opinions and is not intended to defame or discredit any religion, ethnic group, club, organisation, company, individual, or any entity or individual.